NeoGenomics Inc. (NASDAQ: NEO) Starts Presentation at The LD 500
NeoGenomics Inc. (NASDAQ: NEO) specializes in cancer genetics testing and information services. The company provides one of the most comprehensive oncology-focused testing menus in the world to help physicians diagnose and treat cancer. The company's pharma services division serves pharmaceutical clients in clinical trials and drug development. Headquartered in Fort Myers, Florida, NeoGenomics operates CAP accredited and CLIA certified laboratories in Fort Myers and Tampa, Florida; Aliso Viejo, Carlsbad, Fresno and San Diego, California; Houston, Texas; Atlanta, Georgia; and Nashville, Tennessee. It also operates CAP accredited laboratories in Rolle, Switzerland, and Singapore. NeoGenomics serves the needs of pathologists, oncologists, academic…







